Think Non-Invasive.

Introducing uroNIRS 2000 Bladder Monitor System
         
Bright Ideas at Work

Urodynamix's innovative diagnostic technology, based on the principles of near infrared spectroscopy (NIRS), represents a breakthrough in the non-invasive diagnosis of urologic and vascular conditions.

We are developing products for the screening, diagnosis and treatment of urologic and vascular conditions, including lower urinary tract symptoms, overactive bladder, prostate cancer, benign prostatic hyperplasia, and erectile dysfunction.

Urodynamix is listed on the TSX Venture Exchange under the symbol URO.

Latest News & Highlights

CEO Clips




First uroNIRS 2000™ shipment to MMS for E.U. launch complete.

Urodynamix partners with Suntek Medical Systems to market uroNIRS 2000™ in South Korea.

More news...